What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
David Ritchie spends much of his time researching Immunology, Internal medicine, Lymphoma, Antigen and Chemotherapy.
Immunology and Cancer research are frequently intertwined in his study.
His research on Internal medicine frequently connects to adjacent areas such as Oncology.
His Lymphoma study combines topics in areas such as Positron emission tomography and Retrospective cohort study.
His Antigen research is multidisciplinary, incorporating perspectives in Cytotoxic T cell and Cell biology.
His biological study deals with issues like Aldesleukin, which deal with fields such as Pharmacology.
His most cited work include:
- Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma (380 citations)
- Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma (380 citations)
- Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia. (252 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Transplantation, Immunology, Oncology and Hematopoietic stem cell transplantation.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Surgery.
His study on Graft-versus-host disease is often connected to Hazard ratio as part of broader study in Transplantation.
His is involved in several facets of Immunology study, as is seen by his studies on Antigen, T cell, Immune system, Leukemia and Myeloid leukemia.
His Chemotherapy regimen study in the realm of Oncology interacts with subjects such as In patient.
Within one scientific family, David Ritchie focuses on topics pertaining to Radiology under Lymphoma, and may sometimes address concerns connected to Nuclear medicine.
He most often published in these fields:
- Internal medicine (88.66%)
- Transplantation (72.87%)
- Immunology (46.76%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (88.66%)
- Transplantation (72.87%)
- Stem cell (28.14%)
In recent papers he was focusing on the following fields of study:
David Ritchie mainly investigates Internal medicine, Transplantation, Stem cell, Oncology and Cancer research.
His Internal medicine research incorporates elements of Gastroenterology and Viremia.
His research in the fields of Hematopoietic stem cell transplantation and Post transplant overlaps with other disciplines such as Platelet Engraftment.
His research in Stem cell focuses on subjects like Registry study, which are connected to Myeloablative conditioning, Diffuse large B-cell lymphoma and Pathology.
David Ritchie has researched Oncology in several fields, including Cancer, Chemotherapy, B-cell lymphoma, Disease and Bone marrow.
David Ritchie has included themes like Venetoclax and T cell, CD8, Immune system in his Cancer research study.
Between 2019 and 2021, his most popular works were:
- Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance. (46 citations)
- Differential effects of BTK inhibitors ibrutinib and zanubrutinib on NK-cell effector function in patients with mantle cell lymphoma. (14 citations)
- Value and affordability of CAR T-cell therapy in the United States. (8 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
David Ritchie mainly focuses on Internal medicine, Transplantation, Cancer research, Oncology and Chimeric antigen receptor.
His Gastroenterology research extends to the thematically linked field of Internal medicine.
His work on Hematopoietic stem cell transplantation and Graft-versus-host disease as part of general Transplantation research is frequently linked to Exome sequencing, bridging the gap between disciplines.
The various areas that David Ritchie examines in his Cancer research study include Cell and Stem cell.
David Ritchie focuses mostly in the field of Cell, narrowing it down to matters related to Ibrutinib and, in some cases, Mantle cell lymphoma and Lymphoma.
His research investigates the connection between Oncology and topics such as Inflammation that intersect with problems in Immune system.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
